The authors demonstrated that CL-4RNV616 binds and inhibits EGFR, has high stability in human serum, and increases apoptosis in cancer cells; in breast cancer, biopsy-based immunostaining demonstrated high EGFR, but no data were given on GBM tissues [40]. The gene discussed is EGFR; the disease is breast carcinoma.